Background Laparoscopic inguinal hernia surgery is increasingly seen as the superior technique in hernia repair. Compared to open-mesh hernia repair, laparoscopic approaches are often reported to be more cost-effective but incur higher costs for the provider. The objective of this study was to analyze the effect of transabdominal preperitoneal (TAPP) and totally extraperitoneal (TEP) repair of nonincarcerated inguinal hernias in men on hospital costs and length of stay (LoS). Methods We used routine administrative, highly standardized, patient-level cost data from 15 German hospitals participating in the national cost data study. We compared TEP, TAPP, and open-mesh repair. We conducted propensity score matching to account for baseline differences between treatment groups and subsequently estimated the treatment effect on costs and LoS. Results Total costs for both TEP and TAPP surgery were significantly lower than those for open-mesh repair (p \ 0.0001 and p \ 0.05, respectively). TEP repair also had a slight but nonsignificant advantage in total costs compared to TAPP repair, while TAPP surgery was associated with a significantly shorter LoS than TEP (p \ 0.001).
As one of the most frequent surgical procedures worldwide [1] , inguinal hernia repair is subject to extensive research and continuous development. Current surgical techniques include open and laparoscopic approaches. Open hernia surgery is further differentiated into suture repair without using mesh (mostly according to Shouldice) and openmesh repair (mostly according to Lichtenstein) [1, 2] . Laparoscopic approaches include transabdominal preperitoneal (TAPP) and totally extraperitoneal (TEP) repair, both of which use mesh [3] . Laparoscopic inguinal hernia surgery is increasingly seen as the superior technique in hernia repair but it has been associated with higher hospital costs than open-mesh procedures [4] [5] [6] [7] [8] [9] , whereas in longterm cost-effectiveness studies this difference decreases [5, 7, 10] .
Cost studies are often a by-product of clinical trials (e.g., see [5, 10] ) in which cost data rely mostly on charges or estimates as not all hospitals have detailed patient-level cost data available. Hospitals participating in the German national cost data study for evaluation of reimbursement rates are obliged to report costs incurred in a detailed and highly standardized manner [11] . This offers a unique opportunity to evaluate the costs of different procedures based on routine data. Only recurrent costs are accounted for in the national cost data study, as investment costs (such as for laparoscopic equipment) are not financed through reimbursement in Germany [12] .
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Materials and methods
We obtained case-level hospital data from 31 German hospitals participating in the national cost data study conducted by the Erratum: Official translation for InEK: Institute for the Hospital Remuneration System (Institut für das Entgeltsystem im Krankenhaus, InEK). Sociodemographic, medical, and treatment information as well as cost data are reported. Medical information is encoded according to the German-modified version of ICD-10 and treatment information is given using German procedure codes (Operationen-und Prozedurenschlüssel, OPS). Cost data do not include investment costs [11] . Data transmitted by hospitals is anonymised and does not include patient identifiers.
First, cases were identified according to principal diagnoses K40.9-(nonincarcerated unilateral inguinal hernia) and K40.2-(nonincarcerated bilateral inguinal hernia), which reduced the number of hospitals included to 22. Female patients, emergency patients, patients under the age of 18, patients with postoperative complications, patients with peritoneal adhesions, and patients staying in intensive care units were excluded. Patients who underwent TEP repair were identified via procedure code 5-530.32, TAPP repair via procedure code 5-530.31 , and open-mesh hernia repair via procedure code 5-530.30. We thus created three treatment categories: TEP, TAPP, and open-mesh. Other procedure codes apply to patients who previously underwent hernia surgery. We excluded this group as treatment decisions might be influenced by the previously used technique and this information was not included in our data [2] .
We defined five outcome variables: total costs, operating theatre costs, anesthesia costs, ward costs, and LoS. LoS was calculated as the difference between date of admission and date of discharge. Cases with missing values in one of these outcome variables were excluded.
To account for baseline differences in the treatment groups, we applied propensity score matching (PSM) [13] [14] [15] . To calculate propensity scores, i.e., the probability for a case being assigned to a certain treatment group, we used multivariate logistic regression [16, 17] . The model included those variables that potentially influence both treatment selection and outcome [14] . In our preselected sample, laterality remained as one apparent confounder. We also included the enhanced ICD-10-based weighted global Charlson index score (WCIS) [18, 19] to account for comorbidities. For calculation, we identified the relevant ICD-10 codes for secondary diagnoses. The six most severe among the 17 dimensions proposed by Charlson were overweighted. ''Hemiplegia/Paraplegia'', ''Renal disease'', and ''Cancer (any malignancy)'' were weighted by a coefficient of 2; ''Cases of moderate or severe liver disease'' by a coefficient of 3; and ''Metastatic solid tumour'' and ''HIV/ AIDS'' by a coefficient of 6 (see [18] ). Furthermore, we included the following four age categories in the model: (1) 18-30 years. Treatment decisions for this group of patients are influenced by considerations of possible recurrence and infertility [2] . (2) 31-54 years. (3) 55-69 years. In German hospital reimbursement, the age of 55 constitutes a split variable, leading to higher reimbursement in inguinal hernia surgery for those over 55 [20] , thus possibly influencing providers' treatment decisions. (4 )[70 years. Those in this group and the 55-69-year group possibly consume resources at a higher rate. We included the respective hospitals as confounding variables. Dichotomous dummy variables were created for all variables except WCIS.
We matched the groups in question according to the propensity scores calculated for each case. To this end, we used one-to-one caliper matching with replacement. Standardized differences before and after matching were used to assess matching quality [21] . In an iterative approach [21] , we chose a caliper width of 0.0001. Matched samples were used for further statistical analysis and nonmatched cases were excluded. See Fig. 1 for an illustrated summary of our approach.
We compared open-mesh, TEP, and TAPP repair. We thus conducted three PSMs with the same model except for the dependent variable (TEP, TAPP, and again TEP). For each PSM, only those cases that were treated with one of the two respective treatment options and that came from a hospital that performed both of the procedures in question were selected, thus creating three different data sets (see also Fig. 1 and Supplementary Table 1) .
Group comparisons were conducted using Wilcoxon's signed-rank test to account for the paired, nonparametric structure of the data [22] . A p \ 0.05 was considered statistically significant. All analyses were performed with SAS v9.3 (SAS Institute, Cary, NC, USA).
Results
The initial selection of cases according to principal diagnosis, gender, and procedure coding led to a sample of 1,398 cases from 15 hospitals. Descriptive data of the sample is presented in 
Discussion
We evaluated hospital costs associated with laparoscopic and open techniques for tension-free repair of nonincarcerated inguinal hernia in men based on German routine patient-level data. Rather than supporting patient-level clinical decision-making, we aimed to give a detailed understanding of patient-level actual hospital resource consumption connected to different techniques in hernia surgery. The advantage of our approach was the high level of standardization and direct documentation of cost data used. The disadvantages of observational data were partly overcome by performing PSM in order to level out baseline differences of the patients compared. However, our data were collected from a small sample of German hospitals and absolute amounts of costs should be interpreted with care as these will be biased by the structure and the efficiency of the hospitals included (see also Supplementary Table 1) . Another shortcoming of our approach is the scarcity of clinical data, with the lack of American Society of Anesthesiologists (ASA) scores and information on possible previous abdominal surgery being the most apparent flaw. Additionally, there is no information on the medical personnel who performed the procedure. While the suitability for general anesthesia and previous surgery might influence treatment assignment [2, 23] , the experience of the surgeon is surely one of the most influential factors regarding operating costs of inguinal hernia [1, 7, 10] , though it is rarely accounted for in prospective randomized trials. By matching the treatment groups according to hospital, this disadvantage of missing surgeon information is partly overcome as presumably, during the period of 1 year, a relatively narrow group of surgeons will have performed the procedures. Nevertheless, it remains open whether all surgeons have performed both procedures in question. Furthermore, the data used do not include information on the laparoscopic equipment (disposable/reusable) and the type of anesthesia used (local/regional/general). Assignment of causality based on our study thus remains limited as the above-mentioned criteria were not observed. In this respect, double-blinded randomized controlled trials are most reliable regarding assessment of causality [24] . Yet, routine patient-level data are more likely to reflect clinical reality than prospective clinical trials [25] , and it has been argued that well-designed analyses of observational data also allow for valid conclusions [26] . Bearing in mind the limitations of the study, our results suggest that TEP surgery is associated with significantly [7, 10] . Yet others found TEP to be associated with higher hospital costs and higher costs in the long term [5] . These studies do, however, refer to data collected before 2004 and others have demanded careful application of results from the earlier days of laparoscopic hernia surgery to today's situation, with laparoscopic techniques being further advanced and standardized [2] . Additionally, investment costs for laparoscopic equipment have been included in the study by Eklund et al. [5] and the economic analysis of McCormack et al. [7] which were not considered in our study. And while both Langeveld et al. [10] and Eklund et al. [5] presented data from welldesigned prospectively randomized and controlled clinical trials, at least part of the cost data seems to rely on estimates.
Comparing TAPP to open-mesh repair in our sample shows a significantly shorter LoS and thus also lower ward costs. Shorter LoS and faster return to normal activities after laparoscopic surgery have been reported previously [7, [27] [28] [29] . Presumably, the shorter LoS for TAPP also led to lower ward costs in our sample, which in return is the reason for the significantly lower total costs. In contrast, TAPP does not seem advantageous compared to open-mesh repair in other cost categories. This is in line with other studies [4, 8] , but for both these studies, it remains unclear in how far investment costs of equipment were included.
When comparing TEP and TAPP, the short LoS associated with TAPP in our sample is striking. While TEP is less resource-intensive than TAPP in most categories, it is not so in ward costs. This is the reason why total costs for TEP are only modestly and not significantly lower than those for TAPP-treated cases. Otherwise, the results suggest a cost advantage for TEP over TAPP. Studies comparing costs of TEP and TAPP are rare. A randomized trial comparing only the operating costs of TEP and TAPP did not find significant differences in costs for the two procedures [30] . In general, it is important to bear in mind that while there are differences from country to country, day surgery is increasingly common and indeed recommended for the treatment of inguinal hernia [2] . Thus, for some settings the interpretation of results for operating theatre costs might be more relevant than looking at total costs. Finally, when interpreting our results, it is important to remember that the cases for PSM are selected from the full sample that can best be matched to each other according to the model specified and not those cases that are most representative for the full sample. This makes comparisons between matched groups highly valid, but it may also lead to different averages for the same procedure depending on the matching conducted.
In summary, we provided detailed information on cost allocation for different techniques currently used for inguinal hernia surgery. Group comparisons after PSM showed significantly lower costs and shorter LoS for TEP repair compared to open-mesh surgery. TEP repair also showed slight advantages compared to TAPP repair with SD standard deviation; Max maximum; Min minimum; Lower 95 % lower limit of 95 % confidence interval; Upper 95 % upper limit of 95 % confidence interval; LoS length of stay; n = frequency; TAPP transabdominal preperitoneal hernia repair; TEP totally extraperitoneal hernia repair p \ 0.05 considered significant respect to hospital costs. These results suggest that laparoscopic and especially TEP surgery can also be an economically attractive treatment option from a provider's perspective, assuming that reimbursement of both approaches is similar. Comparisons of our results to cost data from clinical trials suggest that higher-quality cost data should be collected during large clinical trials as a connection of both approaches (directly documented cost data and extensive clinical observations) will allow for more valid conclusions.
